Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

Learners show how they built model racing car for international competition
2009-11-10

The Faculty of Natural and Agricultural Sciences at the University of the Free State (UFS) has sponsored a group of learners from Afrikaans Secondary School in Sasolburg to participate in the international round of the F1 in Schools Competition in London in the United Kingdom in September 2009. The F1 in Schools is a competition where schools are challenged to build compact, gas cylinder-driven model racing cars. The team, who competed with a team of Germany against the national winners of other countries, recently did a presentation for the Faculty to tell about the competition and to thank the Faculty for its sponsorship. Here are, from the left: Mr Eugene Wilsenach from F1 in Schools; Heleen van Greunen, Afrikaans Secondary School Sasolburg; Prof. Herman van Schalkwyk, Dean: Faculty of Natural and Agricultural Sciences; and Prof. Neil Heideman, Vice-Dean of the Faculty; back: Chacques van der Vyfer, goods manager; Rohan Laas, graphic designer; Wynand Holtzhausen, design manager; Scholtz Thiart, manufacturing manager; Dekker Coetsee, financial manager; and Helgaard Janse van Rensburg, team manager
Photo: Stephen Collett

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept